These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9024633)

  • 41. DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling.
    Kaina B
    Biochem Pharmacol; 2003 Oct; 66(8):1547-54. PubMed ID: 14555233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of programmed cell death by the p53 pathway.
    Kuribayashi K; El-Deiry WS
    Adv Exp Med Biol; 2008; 615():201-21. PubMed ID: 18441595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of p53-induced apoptosis: in search of genes which are regulated during p53-mediated cell death.
    Choisy-Rossi C; Reisdorf P; Yonish-Rouach E
    Toxicol Lett; 1998 Dec; 102-103():491-6. PubMed ID: 10022301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
    Puca R; Nardinocchi L; Givol D; D'Orazi G
    Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.
    Barnes BJ; Kellum MJ; Pinder KE; Frisancho JA; Pitha PM
    Cancer Res; 2003 Oct; 63(19):6424-31. PubMed ID: 14559832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53 tumor-suppressor gene: clues to molecular carcinogenesis.
    Wang XW; Harris CC
    J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The p53 tumour suppressor gene.
    Steele RJ; Thompson AM; Hall PA; Lane DP
    Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling.
    Lo PK; Huang SZ; Chen HC; Wang FF
    Cancer Res; 2004 Dec; 64(23):8736-45. PubMed ID: 15574785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
    Feng Z; Hu W; de Stanchina E; Teresky AK; Jin S; Lowe S; Levine AJ
    Cancer Res; 2007 Apr; 67(7):3043-53. PubMed ID: 17409411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells.
    Chopin V; Toillon RA; Jouy N; Le Bourhis X
    Br J Pharmacol; 2002 Jan; 135(1):79-86. PubMed ID: 11786482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis.
    Attardi LD; Lowe SW; Brugarolas J; Jacks T
    EMBO J; 1996 Jul; 15(14):3693-701. PubMed ID: 8758936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. mdmx is a negative regulator of p53 activity in vivo.
    Finch RA; Donoviel DB; Potter D; Shi M; Fan A; Freed DD; Wang CY; Zambrowicz BP; Ramirez-Solis R; Sands AT; Zhang N
    Cancer Res; 2002 Jun; 62(11):3221-5. PubMed ID: 12036937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status.
    Chondrogianni N; Trougakos IP; Kletsas D; Chen QM; Gonos ES
    Aging Cell; 2008 Oct; 7(5):717-32. PubMed ID: 18691182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ING1b decreases cell proliferation through p53-dependent and -independent mechanisms.
    Tsang FC; Po LS; Leung KM; Lau A; Siu WY; Poon RY
    FEBS Lett; 2003 Oct; 553(3):277-85. PubMed ID: 14572637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo.
    Palacios G; Moll UM
    Oncogene; 2006 Oct; 25(45):6133-9. PubMed ID: 16682948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Telomeres, p53 and cellular senescence.
    Wynford-Thomas D
    Oncol Res; 1996; 8(10-11):387-98. PubMed ID: 9114431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 family in development.
    Danilova N; Sakamoto KM; Lin S
    Mech Dev; 2008; 125(11-12):919-31. PubMed ID: 18835440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer.
    Artandi SE; Attardi LD
    Biochem Biophys Res Commun; 2005 Jun; 331(3):881-90. PubMed ID: 15865944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cellular response to p53: the decision between life and death.
    Sionov RV; Haupt Y
    Oncogene; 1999 Nov; 18(45):6145-57. PubMed ID: 10557106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The yin and yang of p53 in cellular proliferation.
    Deppert W
    Semin Cancer Biol; 1994 Jun; 5(3):187-202. PubMed ID: 7948947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.